anti-CD20 CAR T cells C-CAR066
Term · Oncology and biomedicine · MLC-T-ONC-010288
A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) cluster of differentiation 20 (CD20), with potential immunostimulating and antineoplastic activities. Upon administration, C-CAR066 specifically recognize and kill CD20-expressing tumor cells. The CD20 antigen, a non-glycosylated cell surface phosphoprotein, is a B-cell specific cell surface antigen expressed in B-cell lineage malignancies and certain melanoma cell subpopulations.
| Identifier | MLC-T-ONC-010288 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CBM.CD20 CAR T C-CAR066; autologous anti-CD20 CAR T cells C-CAR066 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010288",
"term": "anti-CD20 CAR T cells C-CAR066",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) cluster of differentiation 20 (CD20), with potential immunostimulating and antineoplastic activities. Upon administration, C-CAR066 specifically recognize and kill CD20-expressing tumor cells. The CD20 antigen, a non-glycosylated cell surface phosphoprotein, is a B-cell specific cell surface antigen expressed in B-cell lineage malignancies and certain melanoma cell subpopulations.",
"synonyms": [
"CBM.CD20 CAR T C-CAR066",
"autologous anti-CD20 CAR T cells C-CAR066"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-cd20-car-t-cells-c-car066/"
}
Record 1,374 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.